Arca Biopharma’s Q2 loss grows year over year by $1.6M

Facebook Twitter Google+ LinkedIn Email PrintWESTMINSTER — Arca Biopharma Inc., which researches genetic therapies for cardiovascular disease, posted a net loss per share of 59 cents in the second quarter 2017, an increase from its loss of 43 cents per share during the same period last year. The pharmaceutical company lost about $1.6 million more in Q2 2017 than it did in 2016, going from a loss of $3.9 million to $5.5 million. Operating expenses…